Featured image for “Cochlear’s Nucleus Nexa System Earns Spot on TIME’s 2026 Best Inventions List”
Oct. 21, 2026

Cochlear’s Nucleus Nexa System Earns Spot on TIME’s 2026 Best Inventions List

HHTM
LONE TREE, COLORADO — Cochlear Limited announced that its Cochlear Nucleus Nexa System has been named one of TIME’s Best Inventions of 2026, recognizing the cochlear implant platform’s ability to support future technology updates within the implanted device itself. The recognition follows the system’s introduction in 2025, when Cochlear unveiled a new implant architecture designed to extend the potential for
Featured image for “Audiology at a Crossroads: New Study Examines Workforce Growth, Retention, and Future Demand”
Oct. 20, 2026

Audiology at a Crossroads: New Study Examines Workforce Growth, Retention, and Future Demand

HHTM
A new analysis published in Seminars in Hearing raises concerns about the long-term sustainability of the U.S. audiology workforce, finding that the profession has grown substantially more slowly than comparable healthcare disciplines despite an expanding population of people with hearing loss. The study, authored by Victor Bray, PhD, and Amyn M. Amlani, PhD, examines workforce trends spanning more than two
Featured image for “Sound Pharma’s SPI-1005 Shows Promising Hearing Results in Phase 3 Analysis”
Oct. 19, 2026

Sound Pharma’s SPI-1005 Shows Promising Hearing Results in Phase 3 Analysis

HHTM
SEATTLE, WASHINGTON — Sound Pharmaceuticals has presented a new analysis of Phase 3 clinical trial data showing significant improvements in hearing thresholds and speech understanding among patients with Ménière’s disease treated with its investigational oral drug, SPI-1005. The findings, presented at the 2026 American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) Annual Meeting in Los Angeles, suggest the treatment may
Featured image for “Ting Therapeutics Receives Approval to Begin Clinical Trial for Cisplatin-Induced Hearing Loss”
Oct. 19, 2026

Ting Therapeutics Receives Approval to Begin Clinical Trial for Cisplatin-Induced Hearing Loss

HHTM
SAN DIEGO, CALIFORNIA —  Ting Therapeutics has announced that its investigational drug TT004 has received approval to begin clinical testing in China, clearing the way for a Phase Ib study evaluating its potential to protect patients from the harmful effects of cisplatin chemotherapy, including treatment-related hearing loss. The study, which will be conducted at Eye and ENT Hospital of Fudan
Featured image for “Study Finds Older Adults Prefer Traditional Medical Settings for Hearing Care”
Oct. 16, 2026

Study Finds Older Adults Prefer Traditional Medical Settings for Hearing Care

HHTM
A newly published study in BMC Geriatrics finds that older adults consistently prefer receiving hearing healthcare information, testing, and hearing devices through traditional medical settings rather than retail stores, online channels, or other nonmedical alternatives. Published October 13, 2026, the research examined survey responses from adults aged 60 and older in Australia, Canada, England, and the United States. The findings
Featured image for “Beltone Collects More Than 20,000 Food Items in Third Annual Hear2End Hunger Food Drive”
Oct. 16, 2026

Beltone Collects More Than 20,000 Food Items in Third Annual Hear2End Hunger Food Drive

HHTM
CHICAGO, ILLINOIS — Beltone announced that its third annual Hear2End Hunger Food Drive collected 20,640 non-perishable food items for local food banks and hunger-relief organizations across the United States, surpassing its goal of 20,000 items. The month-long initiative, held throughout September in recognition of Hunger Action Month, saw collections increase by more than 41% compared with 2025. Since the program began
Featured image for “Inside Starkey Omega AI+ Hearing Aids: Quad DNN, Better Speech and New Health Features”
Oct. 14, 2026

Inside Starkey Omega AI+ Hearing Aids: Quad DNN, Better Speech and New Health Features

HHTM
Starkey’s new Omega AI+ hearing aids introduce a Quad DNN processing architecture, enhanced speech-in-noise technology, improved feedback management, and new sleep-tracking capabilities. But what do these advancements mean for hearing aid users and hearing care professionals? Reporting from Starkey Day in Minneapolis, Andrew Bellavia speaks with three of Starkey’s senior leaders to explore the technology behind Omega AI+ and the
Featured image for “Taking the Scare Out of Tinnitus (and Avoiding the Traps That Keep It Scary)”
Oct. 14, 2026

Taking the Scare Out of Tinnitus (and Avoiding the Traps That Keep It Scary)

HHTM
By Dr. Jennifer J. Gans For many people, tinnitus is unsettling from the moment it begins. Hearing ringing, buzzing, or humming without an obvious external source can prompt an immediate question: Is something wrong? That uncertainty can set off a powerful response. The brain becomes alert to an unfamiliar sensation, attention narrows, and the sound may begin to feel increasingly
Featured image for “Phonak Launches AI-Powered Roger On Sphere for Hearing Aid and Cochlear Implant Users”
Oct. 14, 2026

Phonak Launches AI-Powered Roger On Sphere for Hearing Aid and Cochlear Implant Users

HHTM
STÄFA, SWITZERLAND – Phonak has announced the launch of Roger On Sphere™, a new wireless remote microphone that incorporates deep neural network (DNN) technology to separate speech from background noise in real time. The device brings AI-based speech enhancement to the company’s established Roger microphone platform, with the goal of improving communication in challenging listening environments where hearing aids alone may
Featured image for “Widex Announces U.S. and European Availability of Allure AI Hearing Aids”
Oct. 14, 2026

Widex Announces U.S. and European Availability of Allure AI Hearing Aids

HHTM
LYNGE, DENMARK – Widex, part of WSA, has announced the expansion of its Allure AI RIC hearing aids with Clarity Boost into 15 additional countries, including the United States and major European markets. The expansion brings the company’s dual-processor hearing technology, which combines natural sound processing with user-activated AI noise reduction, to a broader international audience. Alongside the market expansion, Widex